Compare IDEXX Laboratories, Inc. (IDXX) vs Marathon Digital Holdings Inc (MARA) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
IDEXX Laboratories, Inc. vs Marathon Digital Holdings Inc — how do they compare? IDEXX Laboratories, Inc. trades at $518 (market cap $40.43B), while Marathon Digital Holdings Inc trades at $9.65 (market cap $3.83B). The key difference: IDEXX Laboratories, Inc. is far larger — about 10.6× Marathon Digital Holdings Inc's market cap, and Marathon Digital Holdings Inc is trading nearer its 52-week high, IDEXX Laboratories, Inc. nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold IDEXX Laboratories, Inc. for 46 Days and Marathon Digital Holdings Inc for 22 Days on average.
| IDXX | MARA | |
|---|---|---|
Market Cap | $40.43B | $3.83B |
Volume | 692,164 | 47,742,698 |
Sector | Health | Financials |
52-Week High | $766.68 | $22.84 |
52-Week Low | $504.70 | $6.73 |
Typical Hold Time | 46 Days | 22 Days |
Enterprise Value | $41.32B | $5.87B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
IDEXX Laboratories (IDXX) trades at $513.14, up 1.28% with strong fundamentals including 25.03% net income margin and 74.21% ROE. The stock shows bearish technical signals but maintains consistent earnings beats and analyst consensus of $665 price target. Recent acquisition of CoVetAI expands AI capabilities in veterinary workflow intelligence, supporting long-term growth framework.
Outlook remains positive with revenue growth accelerating to $4.3B in 2025 and projected $4.6B in 2026. Key risks include foreign exchange headwinds and weaker U.S. veterinary visits. The 56.5% buy rating from analysts suggests continued confidence in the company's diagnostic innovation pipeline and recurring revenue economics.
MARA stock trades at $9.91, down 4.34% today, showing bearish technical momentum despite recent volatility. The company faces significant fundamental challenges with a net income margin of -429.71% and consecutive quarterly earnings misses. Analyst sentiment remains divided with equal buy/hold ratings, while recent news highlights the stock's sensitivity to broader market movements and Bitcoin-related sector trends.
The outlook remains challenging due to persistent losses and negative profitability metrics. While the consensus price target of $13.25 suggests potential upside, investors face substantial execution risks amid heavy cash burn and competitive pressures in the technology sector.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About IDEXX Laboratories, Inc.
Idexx Laboratories primarily develops, manufactures, and distributes diagnostic products, equipment, and services for pets and livestock. Its key product lines include single-use canine and feline test kits that veterinarians can employ in the office, benchtop chemistry and hematology analyzers for test-panel analysis on-site, reference lab services, and tests to detect and manage disease in livestock. The firm also offers vet practice management software and consulting services to animal hospitals. Idexx gets about 38% of its revenue from outside the United States.
Read more on IDXX →About Marathon Digital Holdings Inc
Marathon Digital Holdings, Inc. is one of the largest publicly traded Bitcoin mining companies in North America. The company focuses on building and operating large-scale, cost-efficient Bitcoin mining facilities. Marathon's strategy centers on increasing its mining hash rate and using sustainable energy sources to expand its Bitcoin production. The company's performance is closely tied to the price of Bitcoin and the overall health of the digital asset mining industry.
Read more on MARA →
